Kaylon L. Bruner‐Tran

Antiangiogenic Agents Are Effective Inhibitors of Endometriosis

M. Louise Hull, D. Stephen Charnock‐Jones, Clement L. K. Chan et al. · The Journal of Clinical Endocrinology & Metabolism · 2003 · 244 citations

Angiogenic Growth Factor, Immunology, Gynecology +17

Immune interactions in endometriosis

Jennifer L. Herington, Kaylon L. Bruner‐Tran, John A. Lucas et al. · Expert Review of Clinical Immunology · 2011 · 222 citations · Full text

Inflammation, Autoimmune Disease, Uterine Receptivity +15

Steroid and Cytokine Regulation of Matrix Metalloproteinase Expression in Endometriosis and the Establishment of Experimental Endometriosis in Nude Mice

Kaylon L. Bruner‐Tran, Esther Eisenberg, Grant R. Yeaman et al. · The Journal of Clinical Endocrinology & Metabolism · 2002 · 194 citations · Full text

Reduced expression of progesterone receptor-B in the endometrium of women with endometriosis and in cocultures of endometrial cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin

Toshio Igarashi, Kaylon L. Bruner‐Tran, Grant R. Yeaman et al. · Fertility and Sterility · 2005 · 158 citations

Infertility, Hormonal Contraceptive, Medicine +10

Developmental exposure to TCDD reduces fertility and negatively affects pregnancy outcomes across multiple generations

Kaylon L. Bruner‐Tran, Kevin G. Osteen · Reproductive Toxicology · 2010 · 156 citations

Infertility, Developmental Biology, Fertility +15